Feed / MYGN

Myriad Genetics, Inc.

MYGN

Healthcare · 6.05 +3.1% today

Jodie read · what matters now

Market cap $560.2M; revenue $824.5M in 2025 and cash fell to $115.2M at June 30 after $24.0M used in operations.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to MYGN, and whether its market group begins moving.

Revenue YoY-1.6%2025-12-31
Operating margin-47.0%-32.2 pts YoY
Latest story10-Q · Jul 31, 2026Read on Struct ↗
Disclosed connections20 verified links17 additional receipts in Pro
Organic co-movement groupMedia & Financial Services · FollowerLast observed group; it is between live snapshots · See active groups →

Who this business touches

The relationships behind MYGN

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

SOPHFiling-linked namepartnerFull receipt with Pro →
BLLNBillionToOne, Inc.competitorFull receipt with Pro →

Depended on by

CAICaris Life Sciences, Inc.supplierFull receipt with Pro →

Filing peers

Companies whose filings use similar operating language.

You can see the shape of the network here. Pro opens 17 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

MYGN is currently a Follower in the organic co-movement group Media & Financial Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for MYGN; it is not active in the latest market snapshot.

Theme membership history

No durable theme membership has been observed for this name yet.